SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$17.62
-0.09 (-0.51%)
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+125.9% upside
Low Target
$34.71
Average Target
$39.80
High Target
$61.57
Current Price
$17.62
Current
$17.62
$17.62
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Scenario Analysis
Bear Case
$34.71
97.0%
Low target
Base Case
$39.80
+125.9%
Avg target
Bull Case
$61.57
+249.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$103.32
-82.9% from high
52-Week Low
$10.42
+69.2% from low
Target vs 52W High
$39.80
-61.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |